Abstract
Background
Efficient blood stabilization is essential to obtaining reliable and comparable RNA analysis data in preclinical operations. PAXgene (Qiagen, Becton Dickinson) and Tempus (Applied Biosystems, Life Technologies) blood collection tubes with RNA stabilizers both avoid preanalytical degradation of mRNA by endogenous nucleases and modifications in specific mRNA concentrations by unintentional up- or down-regulation of gene expression.
Methods
Sixteen different preanalytical conditions were tested in PAXgene and Tempus blood samples from seven donors: different mixing after collection, different fill volumes and different 24-h transport temperature conditions after collection. RNA was extracted by column-based methods. The quality of the extracted RNA was assessed by spectrophotometric quantification, A260/A280 purity ratio, RNA Integrity Number (Agilent Bioanalyzer), miRNA quantative real time polymerase chain reaction (qRT-PCR) on two target miRNAs (RNU-24 and miR-16), mRNA quality index by qRT-PCR on the 3′ and 5′ region of the GAPDH gene, and the PBMC preanalytical score, based on the relative expression levels of the IL8 and EDEM3 coding genes.
Results
When PAXgene RNA and Tempus blood collection tubes were used following the manufacturers’ instructions, there was no statistically or technically significant difference in the output RNA quality attributes. However, the integrity of the RNA extracted from Tempus collection tubes was more sensitive to fill volumes and effective inversion, than to storage temperature, while the integrity of RNA extracted from PAXgene collection tubes was more sensitive to effective inversion and storage temperature than to fill volumes.
Conclusions
Blood collection tubes with different RNA stabilizers present different robustness to common preanalytical variations.
Acknowledgments
We are grateful to Lieke Mevis for assistance in formatting the manuscript.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Baechler E, Batliwalla F, Karypis G, Gaffney P, Moser K, Ortmann W, et al. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun 2004;5:347–53.10.1038/sj.gene.6364098Search in Google Scholar
2. Debey-Pascher S, Hofmann A, Kreusch F, Schuler G, Schuler-Thurner B, Schultze JL, et al. RNA-stabilized whole blood samples but not peripheral blood mononuclear cells can be stored for prolonged time periods prior to transcriptome analysis. J Mol Diagn 2011;13:452–60.10.1016/j.jmoldx.2011.03.006Search in Google Scholar
3. Zhang H, Korenkova V, Sjöback R, Svec D, Björkman J, Kruhoffer M, et al. Biomarkers for monitoring preanalytical quality variation of mRNA in blood samples. PLoS One 2014;9:e111644.10.1371/journal.pone.0111644Search in Google Scholar
4. Malentacchi F, Pizzamiglio S, Wyrich R, Verderio P, Ciniselli C, Pazzagli M, et al. Effects of transport and storage conditions on gene expression in blood samples. Biopreserv Biobank 2016;14:122–8.10.1089/bio.2015.0037Search in Google Scholar
5. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J, et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002;48:1883–90.10.1093/clinchem/48.11.1883Search in Google Scholar
6. Aarem J, Brunborg G, Aas KK, Harbak K, Taipale MM, Magnus P, et al. Comparison of blood RNA isolation methods from samples stabilized in Tempus tubes and stored at a large human biobank. BMC Res Notes 2016;9:430.10.1186/s13104-016-2224-ySearch in Google Scholar
7. German National Cohort (GNC) Consortium. The German National Cohort: aims, study design and organization. Eur J Epidemiol 2014;29:371–82.10.1007/s10654-014-9890-7Search in Google Scholar
8. Hipp G, Vaillant M, Diederich NJ, Roomp K, Satagopam VP, Banda P, et al. The Luxembourg Parkinson’s study: a comprehensive approach for stratification and early diagnosis. Front Aging Neurosci 2018;10:326.10.3389/fnagi.2018.00326Search in Google Scholar
9. Menke A, Rex-Haffner M, Klengel T, Binder EB, Mehta D. Peripheral blood gene expression: it all boils down to the RNA collection tubes. BMC Res Notes 2012;5:1.10.1186/1756-0500-5-1Search in Google Scholar
10. Nikula T, Mykkänen J, Simell O, Lahesmaa R. Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood. Trans Res 2013;161:181–8.10.1016/j.trsl.2012.10.003Search in Google Scholar
11. Kågedal B, Lindqvist M, Farnebäck M, Lenner L, Peterson C. Failure of the PAXgene™ Blood RNA System to maintain mRNA stability in whole blood. Clin Chem Lab Med 2005;43:1190–2.10.1515/CCLM.2005.206Search in Google Scholar
12. Wright C, Bergstrom D, Dai H, Marton M, Morris M, Tokiwa G, et al. Characterization of globin RNA interference in gene expression profiling of whole-blood samples. Clin Chem 2008;54:396–405.10.1373/clinchem.2007.093419Search in Google Scholar
13. Bayatti N, Cooper-Knock J, Bury JJ, Wyles M, Heath PR, Kirby J, et al. Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis. PLoS One 2014;9:e87508.10.1371/journal.pone.0087508Search in Google Scholar
14. Duale N, Lipkin WI, Briese T, Aarem J, Rønningen KS, Aas KK, et al. Long-term storage of blood RNA collected in RNA stabilizing Tempus tubes in a large biobank – evaluation of RNA quality and stability. BMC Res Notes 2014;7:633.10.1186/1756-0500-7-633Search in Google Scholar
15. PAXgene. Technical Note: PAXgene® Blood RNA System. 2014. Accessed 7/12/2018.Search in Google Scholar
16. Chai V, Vassilakos A, Lee Y, Wright JA, Young AH. Optimization of the PAXgene™ blood RNA extraction system for gene expression analysis of clinical samples. J Clin Lab Anal 2005;19:182–8.10.1002/jcla.20075Search in Google Scholar
17. Mathay C, Hamot G, Henry E, Mommaerts K, Thorlaksdottir A, Trouet J, et al. Method validation for extraction of nucleic acids from peripheral whole blood. Biopreserv Biobank 2016;14:520–9.10.1089/bio.2016.0011Search in Google Scholar
18. Kofanova O, Bellora C, Quesada RA, Bulla A, Panadero-Fajardo S, Keipes M, et al. IL8 and EDEM3 gene expression ratio indicates peripheral blood mononuclear cell (PBMC) quality. J Immunol Methods 2018;465:13–9.10.1016/j.jim.2018.11.012Search in Google Scholar
19. Tempus. Tempus™ Spin RNA Isolation Kit: Quick Reference Card. 2008. Accessed 2018.Search in Google Scholar
20. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006;7:3.10.1186/1471-2199-7-3Search in Google Scholar
21. Vermeulen J, De Preter K, Lefever S, Nuytens J, De Vloed F, Derveaux S, et al. Measurable impact of RNA quality on gene expression results from quantitative PCR. Nucleic Acids Res 2011;39:e63.10.1093/nar/gkr065Search in Google Scholar
22. Gallego Romero I, Pai AA, Tung J, Gilad Y. RNA-seq: impact of RNA degradation on transcript quantification. BMC Biol 2014;12:42.10.1186/1741-7007-12-42Search in Google Scholar
23. Häntzsch M, Tolios A, Beutner F, Nagel D, Thiery J, Teupser D, et al. Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and MiRNA profiles. PLoS ONE 2014;9:e113298.10.1371/journal.pone.0113298Search in Google Scholar
24. Günther K, Malentacchi F, Verderio P, Pizzamiglio S, Ciniselli CM, Tichopad A, et al. Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis. Clin Chim Acta 2012;413:779–86.10.1016/j.cca.2012.01.015Search in Google Scholar
©2019 Walter de Gruyter GmbH, Berlin/Boston